Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

629 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Development of PI3K inhibitors: lessons learned from early clinical trials.
Rodon J, Dienstmann R, Serra V, Tabernero J. Rodon J, et al. Nat Rev Clin Oncol. 2013 Mar;10(3):143-53. doi: 10.1038/nrclinonc.2013.10. Epub 2013 Feb 12. Nat Rev Clin Oncol. 2013. PMID: 23400000 Review.
New drugs and new approaches in metastatic bladder cancer.
Bellmunt J, de Wit R, Albiol S, Tabernero J, Albanell J, Baselga J. Bellmunt J, et al. Crit Rev Oncol Hematol. 2003 Aug;47(2):195-206. doi: 10.1016/s1040-8428(03)00082-9. Crit Rev Oncol Hematol. 2003. PMID: 12900012 Review.
Targeted therapy in advanced colon cancer: the role of new therapies.
Tabernero J, Salazar R, Casado E, Martinelli E, Gómez P, Baselga J. Tabernero J, et al. Ann Oncol. 2004;15 Suppl 4:iv55-62. doi: 10.1093/annonc/mdh905. Ann Oncol. 2004. PMID: 15477336 Review. No abstract available.
Phase I pharmacokinetic and pharmacodynamic study of weekly 1-hour and 24-hour infusion BMS-214662, a farnesyltransferase inhibitor, in patients with advanced solid tumors.
Tabernero J, Rojo F, Marimón I, Voi M, Albanell J, Guix M, Vázquez F, Carulla J, Cooper M, Andreu J, Van Vreckem A, Bellmunt J, Manne V, Manning JA, Garrido C, Felip E, Del Campo JM, García M, Valverde S, Baselga J. Tabernero J, et al. J Clin Oncol. 2005 Apr 10;23(11):2521-33. doi: 10.1200/JCO.2005.00.398. Epub 2005 Feb 14. J Clin Oncol. 2005. PMID: 15710949 Clinical Trial.
Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.
Baselga J, Albanell J, Ruiz A, Lluch A, Gascón P, Guillém V, González S, Sauleda S, Marimón I, Tabernero JM, Koehler MT, Rojo F. Baselga J, et al. J Clin Oncol. 2005 Aug 10;23(23):5323-33. doi: 10.1200/JCO.2005.08.326. Epub 2005 Jun 6. J Clin Oncol. 2005. PMID: 15939921 Clinical Trial.
Novel targeted therapies in the treatment of gastric and esophageal cancer.
Tabernero J, Macarulla T, Ramos FJ, Baselga J. Tabernero J, et al. Ann Oncol. 2005 Nov;16(11):1740-8. doi: 10.1093/annonc/mdi355. Epub 2005 Jun 24. Ann Oncol. 2005. PMID: 15980157 Review.
Epidermal growth factor receptor (EGFR) inhibitors in gastrointestinal cancer.
Macarulla T, Casado E, Ramos FJ, Valverde C, Tabernero J. Macarulla T, et al. Onkologie. 2006 Mar;29(3):99-105. doi: 10.1159/000091013. Epub 2006 Mar 3. Onkologie. 2006. PMID: 16514271 Review.
Novel targets in gastric and esophageal cancer.
Valverde CM, Macarulla T, Casado E, Ramos FJ, Martinelli E, Tabernero J. Valverde CM, et al. Crit Rev Oncol Hematol. 2006 Aug;59(2):128-38. doi: 10.1016/j.critrevonc.2006.02.001. Epub 2006 Jul 10. Crit Rev Oncol Hematol. 2006. PMID: 16829119
Pharmacodynamic studies of gefitinib in tumor biopsy specimens from patients with advanced gastric carcinoma.
Rojo F, Tabernero J, Albanell J, Van Cutsem E, Ohtsu A, Doi T, Koizumi W, Shirao K, Takiuchi H, Ramon y Cajal S, Baselga J. Rojo F, et al. J Clin Oncol. 2006 Sep 10;24(26):4309-16. doi: 10.1200/JCO.2005.04.2424. J Clin Oncol. 2006. PMID: 16963731 Clinical Trial.
629 results
Jump to page
Feedback